Cargando…

Polyclonal light chains in cerebrovascular disease

Altered membrane permeability is a hallmark of inflammation and ischemia with systemic spreading. Renal dysfunction is a risk factor for cardiovascular, cerebrovascular, and metabolic diseases. The aim of the present study was to assess proteinuria and urinary polyclonal light chains in acute stroke...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fiori, Patrizia, Luigi, Maria Giannetti, Iurato, Linda, Tammaro, Carminantonio, Esposito, Gigliola, Monaco, Antonio
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2010
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938302/ https://www.ncbi.nlm.nih.gov/pubmed/20856916 http://dx.doi.org/10.2147/NDT.S7529

Ejemplares similares

Brief assessment of negative dysmorphic signs
por: Fiori, Patrizia, et al.
Publicado: (2010)

Polyclonal free light chains: a biomarker of inflammatory disease or treatment target?
por: Brebner, Judith A., et al.
Publicado: (2013)

Development and characterization of polyclonal antibody against human kappa light chain in rabbit
por: Esparvarinha, Mojgan, et al.
Publicado: (2019)

An elevated polyclonal free light chain level reflects a strong interferon signature in patients with systemic autoimmune diseases
por: Bettacchioli, Eléonore, et al.
Publicado: (2021)

Elevated serum polyclonal immunoglobulin free light chains in patients with severe asthma
por: Basile, Umberto, et al.
Publicado: (2023)

Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies
por: Kumar, Shaji, et al.
Publicado: (2019)

Cell Population Data and Serum Polyclonal Immunoglobulin Free Light Chains in the Assessment of COVID-19 Severity
por: Małecka-Giełdowska, Milena, et al.
Publicado: (2021)

The Association between Polyclonal Combined Serum Free Light Chain Concentration and Mortality in Individuals with Early Chronic Kidney Disease
por: Assi, Lakhvir K., et al.
Publicado: (2015)

Correction: The Association between Polyclonal Combined Serum Free Light Chain Concentration and Mortality in Individuals with Early Chronic Kidney Disease
por: Assi, Lakhvir K., et al.
Publicado: (2015)

Development of polyclonal heavy chain antibodies targeting programmed death ligand-1
por: Oghalaie, Akbar, et al.
Publicado: (2023)

Neuron specific enolase in a SARS CoV2 patient
por: Fiori, Patrizia, et al.
Publicado: (2021)

Body dysmorphic disorder: A complex and polymorphic affection
por: Fiori, Patrizia, et al.
Publicado: (2009)

Air Pollution and Polyclonal Elevation of Serum Free Light Chains: An Assessment of Adaptive Immune Responses in the Prospective Heinz Nixdorf Recall Study
por: Ohlwein, Simone, et al.
Publicado: (2021)

Cerebrovascular Disease and Statins
por: Beltrán Romero, Luis M., et al.
Publicado: (2021)

Impact of prior cerebrovascular disease and glucose status on incident cerebrovascular disease in Japanese
por: Oe, Momoko, et al.
Publicado: (2021)

Resistant prolactinoma: Is it monoclonal or polyclonal?
por: Kumar, K. V. S. Hari, et al.
Publicado: (2013)

Conjugation of R-Phycoerythrin to a Polyclonal Antibody and F (ab')2 Fragment of a Polyclonal Antibody by Two Different Methods
por: Mahmoudian, Jafar, et al.
Publicado: (2010)

Antibodies in infectious diseases: polyclonals, monoclonals and niche biotechnology
por: Berry, Jody D., et al.
Publicado: (2011)

A survey on clinical pathways of patients with epilepsy and cerebrovascular diseases or brain tumors
por: Zaccara, Gaetano, et al.
Publicado: (2020)

Persistent hematopoietic polyclonality after lentivirus-mediated gene therapy for Fabry disease
por: Saleh, Amr H., et al.
Publicado: (2023)

The cerebral circulation and cerebrovascular disease II: Pathogenesis of cerebrovascular disease
por: Chandra, Ankush, et al.
Publicado: (2017)

Isolation of Polyclonal Single-Chain Fragment Variable (scFv) Antibodies Against Venomous Snakes of Iran and Evaluation of Their Capability in Neutralizing the Venom
por: Kadkhodazadeh, Maryam, et al.
Publicado: (2020)

Secondary Cerebrovascular Prevention in Light of the COVID-19 Pandemic
por: Padlina, G, et al.
Publicado: (2020)

Polyclonal origin of mouse skin papillomas.
por: Winton, D. J., et al.
Publicado: (1989)

Production of Erythropoietin-Specific Polyclonal Antibodies
por: Maboudi, Kourosh, et al.
Publicado: (2017)

Passive Monoclonal and Polyclonal Antibody Therapies
por: Pelletier, J. Peter R., et al.
Publicado: (2020)

Epitope Fingerprinting for Recognition of the Polyclonal Serum Autoantibodies of Alzheimer's Disease
por: de Oliveira-Júnior, Luiz Carlos, et al.
Publicado: (2015)

Mapping Cerebrovascular Reactivity Impairment in Patients With Symptomatic Unilateral Carotid Artery Disease
por: Sebök, Martina, et al.
Publicado: (2021)

LIGHT CHAIN DEPOSITION DISEASE
por: Vos, Josephine M.I.
Publicado: (2022)

Preparation and Characterization of a Polyclonal Antibody against Brominated Protein
por: Kambayashi, Yasuhiro, et al.
Publicado: (2009)

Anti-Cryptosporidium oocysts polyclonal antibodies for cryptosporidiosis diagnosis and protection
por: Farid, Alyaa, et al.
Publicado: (2023)

The Burden of Cerebrovascular Disease in the United States
por: Tong, Xin, et al.
Publicado: (2019)

Challenges for Cerebrovascular Disease
por: Hacke, Werner, et al.
Publicado: (2010)

Cerebrovascular disease and stroke
por: Pappachan, J, et al.
Publicado: (2008)

Migraine and cerebrovascular disease
por: Di Piero, Vittorio, et al.
Publicado: (2004)

Atherosclerosis and Cerebrovascular Diseases
por: Blaton, Victor
Publicado: (2004)

Headache in cerebrovascular diseases
por: Lu, Jiajie, et al.
Publicado: (2020)

Periostin in cerebrovascular disease
por: Kawakita, Fumihiro, et al.
Publicado: (2019)

Cerebrovascular disease in women
por: Kumar, Aditya, et al.
Publicado: (2021)

Ceramide in cerebrovascular diseases
por: Yuan, Huiqi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_04d4re6k21mnhctdpmauhom5mu